Tags: Competition
CJEU clarifies when reverse payment patent settlements can be anticompetitive
In its ruling of 30 January 2020, the Court of Justice of the European Union (‘CJEU’) has clarified for the first time the criteria governing whether a reverse payment settlement agreement concerning a dispute between the holder of a pharmaceutical patent and a manufacturer of generic medicines is contrary to EU competition law.
New rules in the Walloon Region and their substantial consequences for franchise and commercial lease agreements: do you comply with them?
Since the transfer of the legislative competence for commercial leases from the federal to the regional level, the Walloon legislator has already made use of its new competence by amending the Act of 30 April 1951 on commercial leases in several aspects.
Companies beware! New prohibition in Belgium on the abuse of economic dependence
On 21 March 2019, the Federal Belgian Parliament adopted an Act amending the Code of Economic Law regarding abuses of economic dependence, prohibited terms and unfair market practices in B2B relationships.
Off-label use of medicines and competition law
The Court of Justice of the European Union issued a judgment on the interplay between medicines’ off-label use and competition law.